In the wake of the COVID-19 pandemic, health systems in Tulsa continue to pursue expansion projects that will increase access to services and intensify competition within the provider sector. Health systems are targeting lucrative specialty care, such as oncology, as well as more cost-effective, convenient care, such as ambulatory surgery centers, for growth. These expansions could drive higher levels of medical utilization, including drug utilization. Physician groups are also deploying telehealth solutions such as virtual visits to maintain access to care and are beginning to distribute COVID-19 vaccines. In the payer sector, Blue Cross and Blue Shield of Oklahoma, Humana, UnitedHealthcare, and a subsidiary of Centene have won contracts for managing Oklahoma’s Medicaid program. As the state moves forward with managed Medicaid, it will also expand the program to an estimated 272,000 residents, which could improve the outlook for drug sales.


Related Reports

El Paso | Texas | 2021 | Market Overview Brief

The El Paso market was one of the worst hit by the COVID-19 pandemic as of fall 2020, with health systems straining tremendously to keep up as the number of cases skyrocketed. Under normal conditio...

View Details

Des Moines | Iowa | 2021 | Market Overview Brief

Several growth strategies and long-term plans for the Des Moines market’s influential health systems were disrupted in 2020 following the COVID-19 outbreak. UnityPoint Health and MercyOne, th...

View Details

Charleston | South Carolina | 2021 | Market Overview Brief

MUSC Health is the dominant health system in the market, leaving Trident Health and Roper St. Francis Healthcare to vie for the No. 2 spot. And for the moment, Trident Health has jumped ahead of RS...

View Details

Harrisburg | Pennsylvania | 2021 | Market Overview Brief

Pittsburgh-based ecosystems UPMC Health and Highmark Health continue to shape the Harrisburg market into another front in their statewide competition. UPMC Pinnacle leads the market’s hosp...

View Details